Insider Trades
| Name | Value | Action | Price | Current Price |
|---|---|---|---|---|
George Rachel GEVP, Gen Counsel/Corp Sec $4.2k500 shares BuyJul 8, 2024 $8.48 -- | ||||
News
globenewswire.comKyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meetingglobenewswire.comApr 21
businesswire.comIonis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meetingbusinesswire.comApr 21
globenewswire.comKyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeksglobenewswire.comApr 20
globenewswire.comXenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meetingglobenewswire.comApr 19
globenewswire.comargenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDPglobenewswire.comApr 18